Auto-injector Real Life Handling in Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

July 8, 2020

Study Completion Date

February 26, 2021

Conditions
RA
Interventions
COMBINATION_PRODUCT

Adalimumab

Combined product as Drug is delivered through an autoinjector pen on which real-life patient handling experience is assessed.

Trial Locations (9)

61176

"Communal Noncommercial Enterprise City Clinical Hospital 8 of Kharkiv City Council", Kharkiv

69001

"Municipal Institution Zaporozhye City Clinical hospital No.10", Zaporizhzhya

69600

"CU Zaporizhzhia Regional Clinical Hospital ZRC", Zaporizhzhya

0102

Aleksandre Aladashvili Clinic LLC, Tbilisi

0159

"National Institute of Endocrinology LTD", Tbilisi

"JSC EVEX Hospitals", Tbilisi

Tbilisi Heart and Vascular Clinic LTD, Tbilisi

0167

Georgian Dutch Hospital LLC, Tbilisi

04114

SI D. F. Chebotarev Institute of Gerontology NAMS Ukraine, Kyiv

All Listed Sponsors
lead

Alvotech Swiss AG

INDUSTRY

NCT04224194 - Auto-injector Real Life Handling in Patients | Biotech Hunter | Biotech Hunter